Back
Celldex Therapeutics Stock Price Chart
Potential crash warning signs flashing again on my charts
Here's my #1 indicator to try out now.
Buy
58
CLDX
Celldex Therapeutics
Last Price:
43.77
Seasonality Move:
3.2%
7 Day Trial
ALL ACCESS PASS
$
7
#1 free indicator forecasts the next market drop here
Discover my #1 trading indicator here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing slight buying pressure.
Celldex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.4 | Buy |
| 20-day SMA: | 37.4 | Buy |
| 50-day SMA: | 37.52 | Buy |
| 200-day SMA: | 38.12 | Buy |
| 8-day EMA: | 41.62 | Buy |
| 20-day EMA: | 39.08 | Buy |
| 50-day EMA: | 37.79 | Buy |
| 200-day EMA: | 37.11 | Buy |
Celldex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.9 | Buy |
| Relative Strength Index (14 RSI): | 69.71 | Buy |
| Chaikin Money Flow: | 192826 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.73 - 40.37) | Buy |
| Bollinger Bands (100): | (34.45 - 40.29) | Buy |
Celldex Therapeutics Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 43.76 while CLDX 8-day simple moving average is 41.40, which is a Buy signal.
- The stock price of CLDX is 43.76 while Celldex Therapeutics 20-day SMA is 37.40, which makes it a Buy.
- Celldex Therapeutics 50-day simple moving average is 37.52 while CLDX share price is 43.76, making it a Buy technically.
- CLDX stock price is 43.76 and Celldex Therapeutics 200-day simple moving average is 38.12, creating a Buy signal.
CLDX Technical Analysis vs Fundamental Analysis
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a Buy
The current Celldex Therapeutics [CLDX] share price is $43.76. The Score for CLDX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
43.76
Share Volume:
427.77K
Celldex Therapeutics 52-Week Range
52-Week High:
53.18
52-Week Low:
22.11
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?
The Celldex Therapeutics stock price is 43.76 USD today. -
Will CLDX stock go up or go down?
Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Celldex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is not overvalued.
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 43.76 while CLDX 8-day exponential moving average is 41.62, which is a Buy signal.
- The stock price of CLDX is 43.76 while Celldex Therapeutics 20-day EMA is 39.08, which makes it a Buy.
- Celldex Therapeutics 50-day exponential moving average is 37.79 while CLDX share price is 43.76, making it a Buy technically.
- CLDX stock price is 43.76 and Celldex Therapeutics 200-day simple moving average is 37.11, creating a Buy signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
- CLDX Moving Average Covergence Divergence (MACD) indicator is 1.9, suggesting Celldex Therapeutics is a Buy
- Celldex Therapeutics Relative Strength Index (RSI) is 69.71, which suggest Celldex Therapeutics is overbought
- The Bollinger Bands (25) for Celldex Therapeutics is (32.73 - 40.37), which suggest Celldex Therapeutics is a Buy
- The Bollinger Bands (100) for Celldex Therapeutics is (34.45 - 40.29), which suggest Celldex Therapeutics is a Buy
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.